Vaccine Cold Chain Logistics Market Size, Share & Trends Analysis Report By Service (Storage, Packaging, Transportation), By Packaging Method, By Mode of Transportation, By Holding Temperature Range, By Container, By Region, And Segment Forecasts, 2025-2034

Report Id: 1127 Pages: 180 Last Updated: 04 April 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Global Vaccine Cold Chain Logistics Market Size is valued at USD 3.5 Billion in 2024 and is predicted to reach USD 5.9 Billion by the year 2034 at a 5.3% CAGR during the forecast period for 2025-2034.

Vaccine Cold Chain Logistics Market

Technological advancements have helped in the development of vaccines in recent years. Vaccines are widely used to control infectious diseases as one of the prevention strategies to maintain the sustainable health of the population. The current covid-19 outbreak has significantly created a huge demand for temperature-controlled storage for vaccines across the globe.

Several drug candidates are being developed and tested to treat COVID-19 infection. There are currently over 250 vaccines across seven platforms being designed and trialed to treat COVID-19 infection. Few candidates are about to receive government approval or at the end of late-stage clinical trials of the Covid-19 vaccine in several countries. However, the next challenge that awaits is the cold chain logistics for vaccine distribution in various countries with different weather conditions. The proper cold storage is critical in the case of covid-19 vaccines as they require temperature-controlled storage and distribution to maintain their efficacy and other properties.

As per the white paper published by DHL in December 2020, around 200,000 pallet shipments and 15 million deliveries in cooling boxes, as well as 15,000 flights, will be required across various supply chain set-ups in the next two years to provide global coverage. Thus, the stable, safe, and IT-enabled supply chain framework and durable physical logistics infrastructure would help vaccine distribution globally.

In addition to the Covid-19 vaccine development, breakthroughs in cancer research efforts, growing pharmaceutical industry, augmented investment in R&D for vaccine development, and increased number of refrigerated warehouses are expected to boost the vaccine cold chain logistics market during the forecast period.

The Global Vaccine Cold Chain Logistics market is categorized based on services, packaging methods, mode of transportation, holding temperature range, and container and region.

Market Segmentation

On the basis of services, the market is segmented into storage, packaging, transportation. Based on packaging methods, the market is segmented into dry ice, liquid nitrogen, gel packs. on the basis of mode of transportation, the market is segregated into ground, air, and ocean. Based on the holding temperature range, the market is classified into vaccines requiring refrigerated temperature, vaccines requiring frozen temperature, vaccines requiring cryogenic temperature. On the basis of the containers, the market is segmented into active containers, passive containers.

Based on the region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the forecast period.

Competitive Landscape

Some Of The Key Players In The Vaccine Cold Chain Logistics Market:

  • Cryoport
  • DHL Express
  • GAC
  • Lynden International Logistics
  • PAREXEL
  • United Parcel Service
  • Yusen Logistics
  • DB Schenker
  • CEVA Logistics
  • Q1 Scientific
  • AmeriCold Logistics LLC
  • FedEx Corporation
  • Sofrigam
  • Sartorius AG
  • Intelsius
  • Envirotainer
  • Coldman Logistics
  • B Medical Systems
  • CSafe
  • Other Prominent Player

Recent Developments

  • In August 2023, UPS Healthcare expanded its UPS Premier service to India, another step in upgrading service and technology to satisfy the needs of time- and temperature-sensitive healthcare goods. Indian clients will get UPS Premier Gold service benefits like ‘first-in, first-off’ prioritization, built-in service recovery features in the UPS global network, and 24/7 control tower monitoring.
  • In September 2022, Cryoport Systems established a strategic partnership with BioLife Plasma Services, a branch of the renowned biopharmaceutical company Takeda, to provide reliable and superior cellular starting material for manufacturing critical cellular medicines. The two companies will initially create a novel operational framework in Houston, Texas, to establish comprehensive collection, processing, and distribution services. This would involve merging the local donation facilities of BioLife Plasma Services with Cryoport's newly established global supply chain centre.

The Vaccine Cold Chain Logistics Market Report Scope

Report Attribute Specifications
Market Size Value In 2024 USD 3.5 Billion
Revenue Forecast In 2034 USD 5.9 Billion
Growth Rate CAGR CAGR of 5.3% from 2025 to 2034
Quantitative Units Representation of revenue in US$ Mn,and CAGR from 2025 to 2034
Historic Year 2021 to 2024
Forecast Year 2025-2034
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Service, By Packaging Method, By Mode of Transportation, By Holding Temperature Range, By Container
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape Cryoport, DHL Express, GAC, Lynden International Logistics, PAREXEL, United Parcel Service, Yusen Logistics, DB Schenker, CEVA Logistics, Q1 Scientific, AmeriCold Logistics LLC, FedEx Corporation, Sofrigam, Sartorius AG, Intelsius, Envirotainer, Coldman Logistics, B Medical Systems, CSafe, Other Prominent Player
Customization Scope Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.
Pricing And Available Payment Methods Explore pricing alternatives that are customized to your particular study requirements.

Global Vaccine Cold Chain Logistics Market Segmentation:

Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Services, 2019-2030

  • Storage
  • Packaging
  • Transportation

Vaccine Cold Chain Logistics Market

Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Packaging Methods, 

  • Dry Ice
  • Liquid Nitrogen
  • Gel Packs

Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Mode of Transportation, 

  • Ground
  • Air
  • Ocean

Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Holding Temperature Range, 

  • Vaccines Requiring Refrigerated Temperature
  • Vaccines Requiring Frozen Temperature
  • Vaccines Requiring Cryogenic Temperature

Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Container, 

  • Active Containers
  • Passive Containers

Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Region,

North America Cold Chain Logistics Market Revenue (US$ Mn), by Country, 

  • U.S.
  • Canada

Europe Cold Chain Logistics Market Revenue (US$ Mn), by Country, 

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Cold Chain Logistics Market Revenue (US$ Mn), by Country,

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Cold Chain Logistics Market Revenue (US$ Mn), by Country, 

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Cold Chain Logistics Market Revenue (US$ Mn), by Country, 

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
7948
Security Code field cannot be blank!

Frequently Asked Questions

The key players in the market include Cryoport, DHL Express, GAC, Lynden International Logistics, PAREXEL, United Parcel Service, and Yusen Logistics

Global Vaccine Cold Chain Logistics Market Size is valued at USD 3.5 Billion in 2024 and is predicted to reach USD 5.9 Billion by the year 2034

Global Vaccine Cold Chain Logistics Market is expected to grow at a 5.3% CAGR during the forecast period for 2025-2034

Service, Packaging Method, Mode of Transportation, Holding Temperature Range and Container are the key segments of the Vaccine Cold Chain Logistics Ma

North American region is leading the Vaccine Cold Chain Logistics Market.
Get Sample Report Enquiry Before Buying